Home/South Rampart Pharma/John M. Wetzel
JM

John M. Wetzel

Director of Chemistry Manufacturing & Controls

South Rampart Pharma

Therapeutic Areas

South Rampart Pharma Pipeline

DrugIndicationPhase
SRP-001 (Oral)Acute & Chronic Pain, Neuropathy (Diabetic and Chemotherapy-induced)Phase 2
SRP-001 (IV)Acute Post-Operative PainIND-Enabling
SRP-001 (Topical)Ocular PainIND-Enabling